Detalhe da pesquisa
1.
Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma.
Proc Natl Acad Sci U S A
; 119(34): e2206824119, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969744
2.
PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex.
Proc Natl Acad Sci U S A
; 117(16): 9064-9073, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273388
3.
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Hepatology
; 73(6): 2380-2396, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222246
4.
PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
Proc Natl Acad Sci U S A
; 115(25): E5766-E5775, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866840
5.
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies.
Br J Cancer
; 122(5): 648-657, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857724
6.
BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Proc Natl Acad Sci U S A
; 113(22): 6254-8, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185926
7.
Antitumor activity of miR-1280 in melanoma by regulation of Src.
Mol Ther
; 23(1): 71-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25195599
8.
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.
Proc Natl Acad Sci U S A
; 109(18): 7067-72, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22511720
9.
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.
Mol Cancer Ther
; 22(9): 1100-1111, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440705
10.
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
J Biol Chem
; 286(19): 16606-14, 2011 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21454583
11.
BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
Front Oncol
; 12: 1011173, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530982
12.
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience.
J Pers Med
; 12(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579573
13.
Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication Stress.
Cancers (Basel)
; 13(17)2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503215
14.
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility.
Cancer Res
; 81(11): 2956-2969, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766890
15.
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
J Invest Dermatol
; 141(8): 2028-2036.e2, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610559
16.
Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.
Am J Pathol
; 174(3): 1009-16, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19179607
17.
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9.
Sci Rep
; 10(1): 18489, 2020 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33116269
18.
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Carcinogenesis
; 30(4): 662-70, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221000
19.
Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells.
Clin Cancer Res
; 14(14): 4564-71, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18579663
20.
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma.
Oncogenesis
; 8(8): 42, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409772